top of page
Cancer Blog
- Dr. Robert Nagourney -
Search


For Advanced Biliary Tract Cancer Patients, the Path Forward
Biliary tract cancer afflicts 8,000 patients in the US each year. It is separated into intrahepatic and and extrahepatic.

Dr. Robert A. Nagourney, MD
Feb 253 min read


Why Do Chemotherapy Drugs Work For Some Cancer Patients and Not For Others?
Treatments should really be given more selectively, i.e. “give this chemotherapy only to those people who will benefit from it,” She said.

Dr. Robert A. Nagourney, MD
Nov 19, 20243 min read


Functional Profiling for Cancer is Scientifically Validated by Peer-Review
One of the critical advantages of Functional Profiling over traditional genomic testing is its focus on the actual response of cancer cells.

Dr. Robert A. Nagourney, MD
Feb 9, 20242 min read


What Have Medical Oncologists Lost? Empathy!
Cancer patients approach their diagnosis with a sense of terror. One day they are fine and feeling well and the next, a terminal diagnosis.

Dr. Robert A. Nagourney, MD
Jan 31, 20243 min read


For Advanced Cancer Patients: Whose Life is It Anyway?
Rising corporate influence and focus on reimbursement in medicine now discourage doctors from straying from strict treatment guidelines.

Dr. Robert A. Nagourney, MD
Jan 23, 20243 min read


Hitting Cancer True and Straight: the Role of Tissue Analysis
Although she showed some response, her disease persisted and she was being considered for surgery to remove the residual tumor...

Dr. Robert A. Nagourney, MD
Oct 30, 20233 min read


A Triple Negative Breast Cancer Patient's Journey: Going the Extra Mile
This patient had recurrent breast cancer that upon biopsy proved to be triple negative.

Dr. Robert A. Nagourney, MD
Oct 10, 20233 min read


Pancreatic Cancer Surgery: Know What You Have Consented To!
However, a new dilemma has arisen; the failure of surgeons to comply with Pancreatic Cancer patient’s wishes to have tissue submitted.

Dr. Robert A. Nagourney, MD
Aug 30, 20232 min read


“New” Immune Therapy Active in Late-Stage Cancer Patients
Here in 2023, we
suddenly discover that TIL cells are highly active against cancer, but it was Steven Rosenberg who first described it.

Dr. Robert A. Nagourney, MD
Aug 14, 20233 min read


Stage 4 Cancer Patient Survivals: The Data Is In and It’s Not Good
There has been talk of improved survival in cancer, most progress has reflected screening, early diagnosis, improved staging, and support.

Dr. Robert A. Nagourney, MD
Jul 24, 20232 min read


Challenging Paradigms: The Management of Rectal Cancer
One noteworthy case was a 78-year-old patient successfully treated without surgery.

Dr. Robert A. Nagourney, MD
Jun 26, 20233 min read


Nagourney Cancer Institute: 20-year Experience in 10,000 Patients
At the 2023 American Association for Cancer Research meeting in Orlando, we reported results of ex vivo analysis of programmed cell death.

Dr. Robert A. Nagourney, MD
May 15, 20234 min read


A Year-End Reflection
2022 Reflection. Among our most important accomplishments in 2022 was the installation of a world-class Mass Spectrometry research program.

Dr. Robert A. Nagourney, MD
Dec 30, 20222 min read
The Information Disconnect - Genomics vs Human Cancer Biology
I recently had an interesting conversation with a physician regarding her patient with an aggressive breast cancer. A portion of tumor...

Dr. Robert A. Nagourney, MD
Oct 21, 20134 min read
Functional Profiling Identifies Accurate Genomic Findings
The 2013 American Society of Clinical Oncology annual meeting, held May 31 – June 1, in Chicago, afforded the opportunity to report three...

Dr. Robert A. Nagourney, MD
Jul 9, 20133 min read
Personalized Cancer Care: N-of-1
The New York Yankees catcher Yogi Berra famous quote, “Déjà vu all over again,” reminds me of the growing focus on the concept of “N-...

Dr. Robert A. Nagourney, MD
May 20, 20132 min read
The Future of Cancer Research
The American Association for Cancer Research meeting held April 6 - 10 in Washington DC, provided a scientific perspective on oncologic...

Dr. Robert A. Nagourney, MD
Apr 25, 20133 min read
Cancer as a Metabolic Disorder
I received an inquiry via Twitter “Has anyone thought about using a sugar medium (similar to PET scans) to deliver chemo drugs?” Although...

Dr. Robert A. Nagourney, MD
Apr 19, 20131 min read
bottom of page